Integra Lifesciences Share Price Today
(NASDAQ: IART)

Name: Integra Lifesciences Share Price Today (NASDAQ: IART) - Integra Lifesciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Integra Lifesciences share price is $24.18 & ₹2,098.56 as on 15 Feb 2025, 2.30 'hrs' IST

$24.18

▲

-0.08

(-0.33%)

Market is closed - opens 8 PM, 18 Feb 2025

View live Integra Lifesciences share price in Dollar and Rupees. Guide to invest in Integra Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Integra Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Integra Lifesciences share price movements

Today's Low: $24.08
Today's High: $24.65
$24.18
0.43%
Downside
Day's Volatility :2.33%
Upside
1.91%
52 Weeks Low: $16.81
52 Weeks High: $45.42
$24.18
30.5%
Downside
52 Weeks Volatility :63.0%
Upside
46.76%

Integra Lifesciences (IART) Returns

Period	Integra Lifesciences Holdings Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	7.51%	2.1%	0.0%
6 Months	12.2%	-5.2%	0.0%
1 Year	-46.31%	-0.2%	0.0%
3 Years	-63.94%	11.1%	-14.8%

Integra Lifesciences (IART) Key Statistics

in dollars & INR

Previous Close	$24.26
Open	$24.46
Today's High	$24.65
Today's Low	$24.075
Market Capitalization	$1.9B
Today's Volume	$229.4K
52 Week High	$45.42
52 Week Low	$16.805
Revenue TTM	$1.6B
EBITDA	$323.1M
Earnings Per Share (EPS)	$-0.09
Profit Margin	-0.42%
Quarterly Earnings Growth YOY	-0.6%
Return On Equity TTM	-0.42%

How to invest in Integra Lifesciences Stock (IART) from India?

It is very easy for Indian residents to invest directly in Integra Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Integra Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Integra Lifesciences or IART on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Integra Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Integra Lifesciences shares which would translate to 0.036 fractional shares of Integra Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Integra Lifesciences, in just a few clicks!

Returns in Integra Lifesciences (IART) for Indian investors in Rupees

The Integra Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Integra Lifesciences investment value today

Current value as on today

₹58,247

Returns

₹41,753

(-41.75%)

Returns from Integra Lifesciences Stock

₹46,314 (-46.31%)

Dollar Returns

₹4,561 (+4.56%)

Indian investors sentiment towards Integra Lifesciences (IART)

-38%

Period: Jan 15, 2025 to Feb 14, 2025. Change in 30 Days versus previous period

Search interest for Integra Lifesciences Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Integra Lifesciences

BlackRock Inc
14.11%
Vanguard Group Inc
10.04%
Morgan Stanley - Brokerage Accounts
6.81%
Fuller & Thaler Asset Management Inc
5.14%
AllianceBernstein L.P.
3.92%
State Street Corp
3.66%

Analyst Recommendation on Integra Lifesciences

Buy

50%Buy

35%Hold

15%Sell

Based on 20 Wall street analysts offering stock ratings for Integra Lifesciences(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Integra Lifesciences Stock (IART)

What analysts predicted

Upside of 7.53%

Target:

$26.00

Current:

$24.18

Insights on Integra Lifesciences Stock (Ticker Symbol: IART)

Price Movement
In the last 7 days, IART stock has moved down by -4.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 418.17M → 380.83M (in $), with an average decrease of 8.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -12.40M → -10.69M (in $), with an average increase of 16.0% per quarter
IART vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 60.6% return, outperforming this stock by 106.6%
IART vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 141.1% return, outperforming this stock by 204.9%
Price to Sales
ForIART every $1 of sales, investors are willing to pay $1.2, whereas for Boston Scientific Corp., the investors are paying $9.8 for every $1 of sales.

IART Integra Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.5B	↑ 23.92%
Net Income	$60.8M	↓ 6.09%
Net Profit Margin	4.13%	↓ 1.32%

	FY19	Y/Y Change
Revenue	$1.5B	↑ 3.06%
Net Income	$50.2M	↓ 17.43%
Net Profit Margin	3.31%	↓ 0.82%

	FY20	Y/Y Change
Revenue	$1.4B	↓ 9.6%
Net Income	$133.9M	↑ 166.71%
Net Profit Margin	9.76%	↑ 6.45%

	FY21	Y/Y Change
Revenue	$1.5B	↑ 12.43%
Net Income	$169.1M	↑ 26.28%
Net Profit Margin	10.96%	↑ 1.2%

	FY22	Y/Y Change
Revenue	$1.6B	↑ 0.99%
Net Income	$180.6M	↑ 6.79%
Net Profit Margin	11.59%	↑ 0.63%

	FY23	Y/Y Change
Revenue	$1.5B	↓ 1.03%
Net Income	$67.7M	↓ 62.48%
Net Profit Margin	4.39%	↓ 7.2%

	Q2 FY23	Q/Q Change
Revenue	$381.3M	↑ 0.11%
Net Income	$4.2M	↓ 82.73%
Net Profit Margin	1.1%	↓ 5.26%

	Q3 FY23	Q/Q Change
Revenue	$382.4M	↑ 0.3%
Net Income	$19.5M	↑ 365.99%
Net Profit Margin	5.1%	↑ 4.0%

	Q4 FY23	Q/Q Change
Revenue	$397.0M	↑ 3.82%
Net Income	$19.8M	↑ 1.73%
Net Profit Margin	5.0%	↓ 0.1%

	Q1 FY24	Q/Q Change
Revenue	$368.9M	↓ 7.09%
Net Income	$-3.3M	↓ 116.54%
Net Profit Margin	-0.89%	↓ 5.89%

	Q2 FY24	Q/Q Change
Revenue	$418.2M	↑ 13.37%
Net Income	$-12.4M	↑ 277.99%
Net Profit Margin	-2.97%	↓ 2.08%

	Q3 FY24	Q/Q Change
Revenue	$380.8M	↓ 8.93%
Net Income	$-10.7M	↓ 13.76%
Net Profit Margin	-2.81%	↑ 0.16%

	FY18	Y/Y Change
Profit	$900.9M	↑ 19.69%

	FY19	Y/Y Change
Profit	$952.9M	↑ 5.76%

	FY20	Y/Y Change
Profit	$851.0M	↓ 10.69%

	FY21	Y/Y Change
Profit	$944.6M	↑ 11.0%

	FY22	Y/Y Change
Profit	$970.3M	↑ 2.72%

	FY23	Y/Y Change
Profit	$888.4M	↓ 8.44%

	Q2 FY23	Q/Q Change
Profit	$207.0M	↓ 11.1%

	Q3 FY23	Q/Q Change
Profit	$218.3M	↑ 5.47%

	Q4 FY23	Q/Q Change
Profit	$234.0M	↑ 7.16%

	Q1 FY24	Q/Q Change
Profit	$206.8M	↓ 11.6%

	Q2 FY24	Q/Q Change
Profit	$232.5M	↑ 12.39%

	Q3 FY24	Q/Q Change
Profit	$200.2M	↓ 13.87%

	FY18	Y/Y Change
Operating Cash Flow	$199.7M	↑ 74.33%
Investing Cash Flow	$-49.7M	↓ 95.93%
Financing Cash Flow	$-180.9M	↓ 115.47%

	FY19	Y/Y Change
Operating Cash Flow	$373.7M	↑ 87.14%
Investing Cash Flow	$-162.7M	↑ 227.27%
Financing Cash Flow	$64.5M	↓ 135.64%

	FY20	Y/Y Change
Operating Cash Flow	$203.8M	↓ 45.45%
Investing Cash Flow	$-68.1M	↓ 58.15%
Financing Cash Flow	$121.6M	↑ 88.68%

	FY21	Y/Y Change
Operating Cash Flow	$312.4M	↑ 53.28%
Investing Cash Flow	$-161.4M	↑ 137.16%
Financing Cash Flow	$-98.2M	↓ 180.76%

	FY22	Y/Y Change
Operating Cash Flow	$264.5M	↓ 15.35%
Investing Cash Flow	$-58.6M	↓ 63.71%
Financing Cash Flow	$-252.0M	↑ 156.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$28.3M	↑ 8.12%
Investing Cash Flow	$-15.5M	↑ 13.46%
Financing Cash Flow	$-10.7M	↓ 93.43%

Integra Lifesciences Technicals Summary

Sell

Neutral

Buy

Integra Lifesciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Integra Lifesciences (IART) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Integra Lifesciences Holdings Corp	4.04%	12.2%	-46.31%	-63.94%	-58.89%
Medtronic Plc	6.48%	9.42%	9.94%	-10.02%	-17.62%
Edwards Lifesciences Corp.	9.06%	11.62%	-11.51%	-31.15%	-0.42%
Boston Scientific Corp.	8.09%	34.86%	61.21%	140.12%	151.68%
Stryker Corporation	0.89%	12.94%	10.27%	48.38%	73.56%
Abbott Laboratories	14.66%	16.72%	14.56%	5.6%	46.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Integra Lifesciences Holdings Corp	83.17	NA	0.81	2.45	0.0	0.03	NA	19.73
Medtronic Plc	28.2	28.2	1.57	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	32.42	32.42	5.73	2.46	0.17	0.11	NA	16.18
Boston Scientific Corp.	84.91	84.91	1.88	2.85	0.09	0.05	NA	14.05
Stryker Corporation	49.98	49.98	2.71	13.51	0.19	0.07	0.01	52.86
Abbott Laboratories	17.27	17.27	2.37	5.15	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Integra Lifesciences Holdings Corp	Buy	$1.9B	-58.89%	83.17	-0.42%
Medtronic Plc	Buy	$118.2B	-17.62%	28.2	12.06%
Edwards Lifesciences Corp.	Buy	$44.9B	-0.42%	32.42	76.75%
Boston Scientific Corp.	Buy	$156.4B	151.68%	84.91	11.26%
Stryker Corporation	Buy	$148.2B	73.56%	49.98	16.34%
Abbott Laboratories	Buy	$228.6B	46.95%	17.27	13.99%

About Integra Lifesciences

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Organization	Integra Lifesciences
Employees	3946
CEO	Ms. Mojdeh Poul
Industry	Health Technology

Management People of Integra Lifesciences

Name	Title
Dr. Stuart M. Essig Ph.D.	Non- Executive Chairman
Ms. Lea Daniels Knight	Executive VP & CFO
Mr. Jeffrey A. Mosebrook	Senior VP of Finance & Principal Accounting Officer
Mr. Eric Ian Schwartz J.D.	Executive VP, Chief Legal Officer & Secretary
Mr. Robert T. Davis Jr.	Executive VP & President of Tissue Technologies
Mr. Michael J. McBreen	Executive VP & President of Codman Specialty Surgical
Ms. Mojdeh Poul	President, CEO & Director
Mr. Stephen Leonard	Corporate VP of Global Operations & Supply Chain
Laurene Isip	Vice President of Global Corporate Communications & Public Relations
Ms. Ruth L. Fleming	Vice President of Global Marketing

Important FAQs about investing in IART Stock from India :

What is Integra Lifesciences share price today?

Integra Lifesciences share price today stands at $24.18, Open: $24.46 ; Previous Close: $24.26 ; High: $24.65 ; Low: $24.08 ; 52 Week High: $45.42 ; 52 Week Low: $16.81.

The stock opens at $24.46, after a previous close of $24.26. The stock reached a daily high of $24.65 and a low of $24.08, with a 52-week high of $45.42 and a 52-week low of $16.81.

Can Indians buy Integra Lifesciences shares?

Yes, Indians can invest in the Integra Lifesciences (IART) from India.

With INDmoney, you can buy Integra Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Integra Lifesciences at zero transaction cost.

How can I buy Integra Lifesciences shares from India?

It is very easy to buy Integra Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Integra Lifesciences (IART) be purchased?

Yes, you can buy fractional shares of Integra Lifesciences with INDmoney app.

What are the documents required to start investing in Integra Lifesciences stocks?

To start investing in Integra Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.